The epidemic in India continues to be severe, with the total number of deaths from the epidemic exceeding 300,000. On May 24, Fengtai announced again that it would extend the shutdown until May 30. Fengtai’s current Indian production line accounts for more than 20% of the total production capacity, and it will be supported by other overseas factories during the shutdown.
The COVID-19 epidemic in India is still not under control. Nike’s main shoe manufacturer Fontaine (9910-TW) has suspended 10 jobs in a total of 3 factories in India starting from May 12. sky.
On May 24, Fengtai announced again:
In order to comply with the local government’s epidemic prevention requirements, the shutdown will be extended to May 30 Today, Fengtai’s Indian production line currently accounts for more than 20% of the total production capacity, and will be supported by other overseas factories during the shutdown period.
Fontai pointed out that Indian factories mainly produce simple shoes.
Fengtai originally planned to expand production capacity by 7-10% in overseas factories including India this year. The director of Fengtai pointed out that the current expansion in India and other related The factory case has not stopped.
Fengtai’s after-tax net profit in the first quarter of 2021 was 1.64 billion yuan, a quarterly increase of 35.54%, an annual increase of 28.9%, and a net profit per share of 1.86 yuan.
Fengtai is the main OEM factory for Nike shoes. Last year, the net profit after tax was 4.879 billion yuan, a year-on-year decrease of 21.7%. The net profit per share was 5.53 yuan. Last year, the profit per share was expected to be 4.879 billion yuan. A cash dividend of RMB 3.7 was distributed.
Due to the expansion of the epidemic in Taiwan, all shareholders’ meetings of listed companies have been postponed. The director of Fengtai pointed out that the ex-dividend date will not be decided until the shareholders’ meeting passes the dividend proposal, but no decision has been made yet to postpone it. The exact date will be held later.
The epidemic in India continues to be severe, with the total number of deaths from the epidemic exceeding 300,000
On the 24th, India stated that the cumulative number of people infected with COVID-19 has exceeded 300,000, making it the third country to reach this threshold after the United States and Brazil. This huge wave of epidemic has also overwhelmed India’s medical system. care system.
According to data from the Indian Ministry of Health on the 25th, India had 196,427 new confirmed cases compared with the previous day, and a total of 26,948,874 confirmed cases; there were 3,511 new deaths, and a total of 307,231 deaths.
Many experts believe the actual death toll will be much higher, especially as the epidemic spreads from big cities to rural areas where most of the 1.3 billion people live. Medical facilities and record management are relatively backward.
This wave of epidemic has not only overwhelmed hospitals with patients, but also led to serious shortages of oxygen and key medicines.
Heart-wrenching photos have also emerged in India of long queues waiting for funerals and temporary cremations at crematoria and cemeteries.
The epidemic has dampened manufacturing in India and orders are returning to China! Expert: Foreign companies are afraid of leaving
The epidemic in India is out of control and has become one of the hardest-hit areas in the world. Many Taiwanese factories and multinational companies in India have been forced to suspend operations.
Originally, with the departure of the global supply chain, India was expected to become the “world’s factory.” However, due to the disruption caused by the epidemic, multinational companies have transferred orders back to China.
An adjunct lecturer at New York University and a Chinese management consultant believes that if the epidemic in India does not improve before the summer, some large companies may withdraw from India. </p
